Cargando…
AMPK: a novel target for treating hepatic fibrosis
Fibrosis is a common process of excessive extracellular matrix (ECM) accumulation following inflammatory injury. Fibrosis is involved in the pathogenesis of almost all liver diseases for which there is no effective treatment. 5'-AMP-activated protein kinase (AMPK) is a cellular energy sensor th...
Autores principales: | Liang, Zhenxing, Li, Tian, Jiang, Shuai, Xu, Jing, Di, Wencheng, Yang, Zhi, Hu, Wei, Yang, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617548/ https://www.ncbi.nlm.nih.gov/pubmed/28977988 http://dx.doi.org/10.18632/oncotarget.19376 |
Ejemplares similares
-
AMPK: Potential Therapeutic Target for Ischemic Stroke
por: Jiang, Shuai, et al.
Publicado: (2018) -
Modelling porcine NAFLD by deletion of leptin and defining the role of AMPK in hepatic fibrosis
por: Tan, Tan, et al.
Publicado: (2023) -
MicroRNA-506-3p targets SIRT1 and suppresses AMPK pathway activation to promote hepatic steatosis
por: Hu, Liang-Kai, et al.
Publicado: (2021) -
MicroRNA-506-3p targets SIRT1 and suppresses AMPK pathway activation to promote hepatic steatosis
por: Hu, Liang-Kai, et al.
Publicado: (2022) -
Epigenetic silencing of LncRNA ANRIL enhances liver fibrosis and HSC activation through activating AMPK pathway
por: Yang, Jing‐Jing, et al.
Publicado: (2020)